s6y
Company name or ticker
Search
G1 Therapeutics, Inc.
4
Avagliano Mark: Statement of changes in beneficial ownership of securities
Filed
Wednesday, January 5, 2022
Period
Jan 3, 2022
Accession number
0001562180-22-000303
Documents
PRIMARY DOCUMENT
4
MARK AVAGLIANO POA JUL 2019
EX-24
On sec.gov
Filing index
All files
Complete submission text
SGML header